Lineage, Inc. Common Stock (LINE)vsUniversal Health Realty Income Trust (UHT)
LINE
Lineage, Inc. Common Stock
$35.99
-1.64%
REAL ESTATE · Cap: $8.93B
UHT
Universal Health Realty Income Trust
$40.70
+0.17%
REAL ESTATE · Cap: $566.12M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 5209% more annual revenue ($5.36B vs $100.87M). UHT leads profitability with a 17.7% profit margin vs -1.9%. UHT earns a higher WallStSmart Score of 57/100 (C).
LINE
Hold36
out of 100
Grade: F
UHT
Buy57
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+75.9%
Fair Value
$161.49
Current Price
$35.99
$125.50 discount
Margin of Safety
+51.9%
Fair Value
$89.09
Current Price
$40.70
$48.39 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Strong operational efficiency at 36.5%
Growing faster than its price suggests
Areas to Watch
0.0% earnings growth
ROE of -1.2% — below average capital efficiency
Revenue declined 0.2%
Distress zone — elevated risk
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
Revenue declined 1.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : UHT
The strongest argument for UHT centers on Operating Margin, PEG Ratio. Profitability is solid with margins at 17.7% and operating margin at 36.5%. PEG of 0.63 suggests the stock is reasonably priced for its growth.
Bear Case : LINE
The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.
Bear Case : UHT
The primary concerns for UHT are P/E Ratio, Market Cap, Revenue Growth.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while UHT is a declining play — different risk/reward profiles.
LINE is growing revenue faster at -0.2% — sustainability is the question.
LINE generates stronger free cash flow (78M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
UHT scores higher overall (57/100 vs 36/100), backed by strong 17.7% margins. LINE offers better value entry with a 75.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.
Visit Website →Universal Health Realty Income Trust
REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA
Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service related facilities including intensive care hospitals, rehabilitation hospitals, subacute care facilities, medical / office buildings, emergency departments independent and child care centers.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?